Skip to main content
Premium Trial:

Request an Annual Quote

All the Tea

Premium

In a new study in PNAS, researchers at the University of Missouri describe their use of a compound found in tea leaves to deliver irradiated gold nanoparticles to solid tumors, while getting around the barriers of the tumor microenvironment that can hinder efforts to expose cancer cells to treatment. "It's actually gold salt," says the Columbia Daily Tribune's Janese Silvey. "Mixed with tea, the gold breaks down into nanoparticles. The research team discovered that an injection of radioactive gold nanoparticles coated with a chemical from tea shrinks fast-growing prostate tumors in mice by 70 percent to 80 percent." Radioactive gold nanoparticles have been known to kill cancer cells, but the problem is that they don't target cancer cells specifically — they kill everything they touch, Silvey says. Three years ago, the university's Kattesh Katti found that a compound in tea leaves could coat the gold nanoparticles and keep them from spreading radiation throughout the body. This compound, epigallocatechin-gallate, is also attracted to prostate tumor cells, so it can deliver the gold nanoparticles straight to the tumor. "The gold has a half-life of 2.7 days, so the radioactivity from a dose would be gone in about three weeks," Silvey adds.

The researchers plan to start testing the delivery system on dogs, and then move on to humans. If successful, a treatment could be available in five years, Silvey says.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.